![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Zhuidu Formula suppresses the migratory and invasive properties of triple-negative breast cancer cells via dual signaling pathways of RhoA/ROCK and CDC42/MRCK
Qinhang Wu, Xuelin Ma, Zhuolin Jin, et al.
Journal of Ethnopharmacology (2023) Vol. 315, pp. 116644-116644
Closed Access | Times Cited: 9
Qinhang Wu, Xuelin Ma, Zhuolin Jin, et al.
Journal of Ethnopharmacology (2023) Vol. 315, pp. 116644-116644
Closed Access | Times Cited: 9
Showing 9 citing articles:
Deciphering JAK/STAT signaling pathway: A multifaceted approach to tumorigenesis, progression and therapeutic interventions
Yihui Wang, Zhe Wang, Shuyu Li, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111846-111846
Closed Access | Times Cited: 8
Yihui Wang, Zhe Wang, Shuyu Li, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111846-111846
Closed Access | Times Cited: 8
Role of WAVE3 as an actin binding protein in the pathology of triple negative breast cancer
Kruyanshi Master, Lamyae El Khalki, Mekki Bayachou, et al.
Cytoskeleton (2024)
Open Access | Times Cited: 2
Kruyanshi Master, Lamyae El Khalki, Mekki Bayachou, et al.
Cytoskeleton (2024)
Open Access | Times Cited: 2
Pharmacokinetics–Pharmacodynamics Modeling for Evaluating Drug–Drug Interactions in Polypharmacy: Development and Challenges
Di Zhao, Ping Huang, Li Yu, et al.
Clinical Pharmacokinetics (2024) Vol. 63, Iss. 7, pp. 919-944
Closed Access | Times Cited: 1
Di Zhao, Ping Huang, Li Yu, et al.
Clinical Pharmacokinetics (2024) Vol. 63, Iss. 7, pp. 919-944
Closed Access | Times Cited: 1
From Sea to Science: Coral Aquaculture for Sustainable Anticancer Drug Development
Hung‐Yu Lin, Tsen‐Ni Tsai, Kai‐Cheng Hsu, et al.
Marine Drugs (2024) Vol. 22, Iss. 7, pp. 323-323
Open Access | Times Cited: 1
Hung‐Yu Lin, Tsen‐Ni Tsai, Kai‐Cheng Hsu, et al.
Marine Drugs (2024) Vol. 22, Iss. 7, pp. 323-323
Open Access | Times Cited: 1
Design, synthesis and biological evaluation of a novel PAK1 degrader for the treatment of triple negative breast cancer
Yi Du, Xiya Chen, Wei-Ji Chen, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117896-117896
Closed Access | Times Cited: 1
Yi Du, Xiya Chen, Wei-Ji Chen, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117896-117896
Closed Access | Times Cited: 1
Investigation of the Lipid-Lowering Activity and Mechanism of Three Extracts from Astragalus membranaceus, Hippophae rhamnoides L., and Taraxacum mongolicum Hand. Mazz Based on Network Pharmacology and In Vitro and In Vivo Experiments
Xue Yang, Mingjie Jia, Jiayuan Luo, et al.
Foods (2024) Vol. 13, Iss. 17, pp. 2795-2795
Open Access
Xue Yang, Mingjie Jia, Jiayuan Luo, et al.
Foods (2024) Vol. 13, Iss. 17, pp. 2795-2795
Open Access
Crocetin Enhances Temozolomide Efficacy in Glioblastoma Therapy Through Multiple Pathway Suppression
Wei-En Tsai, Yen-Tsen Liu, Fu-Hsuan Kuo, et al.
Current Neurovascular Research (2024) Vol. 21, Iss. 3, pp. 320-336
Closed Access
Wei-En Tsai, Yen-Tsen Liu, Fu-Hsuan Kuo, et al.
Current Neurovascular Research (2024) Vol. 21, Iss. 3, pp. 320-336
Closed Access
Multidisciplinary examples of applications: Papers using the MAL-PD/BD/CI/BI theory/method
Ting-Chao Chou
Elsevier eBooks (2024), pp. 181-218
Closed Access
Ting-Chao Chou
Elsevier eBooks (2024), pp. 181-218
Closed Access
Crocetin: A Promising Adjunctive Therapy Enhancing Temozolomide Efficacy in Malignant Glioblastoma through Suppression of AKT, ERK, and p38 Signaling Pathways
Wei-En Tsai, Yen-Tsen Liu, Fu-Hsuan Kuo, et al.
Research Square (Research Square) (2023)
Open Access
Wei-En Tsai, Yen-Tsen Liu, Fu-Hsuan Kuo, et al.
Research Square (Research Square) (2023)
Open Access